• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺 X 线筛查:降低 1 例乳腺癌死亡需要筛查的人数新估计。

Mammography screening: a new estimate of number needed to screen to prevent one breast cancer death.

机构信息

Department of Radiology, University of Colorado-Denver, School of Medicine, 12700 E 19th Ave, Mail Stop C278, Aurora, CO 80045, USA.

出版信息

AJR Am J Roentgenol. 2012 Mar;198(3):723-8. doi: 10.2214/AJR.11.7146.

DOI:10.2214/AJR.11.7146
PMID:22358016
Abstract

OBJECTIVE

The purpose of our study was to estimate the number of women needed to screen (NNS) to prevent one breast cancer death and the number needed to screen per life-year gained (NNS/LYG) with annual or biennial screening mammography and to compare NNS to the number needed to invite (NNI) to a screening trial to prevent one breast cancer death.

MATERIALS AND METHODS

Cancer Intervention and Surveillance Modeling Network (CISNET) modeling results commissioned by the United States Preventive Services Task Force (USPSTF) for their 2009 update of breast cancer screening recommendations were used to estimate NNS and NNS/LYG with annual or biennial screening mammography. NNS values were compared with NNI as reported by USPSTF, which used the CISNET results to aid their 2009 recommendation of starting age and screening interval.

RESULTS

For women between the ages of 40 and 49 years undergoing annual screening mammography, CISNET modeling results estimate an NNS of 746, 39% of the NNI of 1904 estimated by USPSTF on the basis of randomized controlled trial (RCT) data. The NNS based on CISNET results for women between 50 and 59 years is 351 (26% of the NNI of 1339 estimated by USPSTF from RCT data), for women between 60 and 69 years is 233 (62% of the NNI of 377 estimated by USPSTF from RCT data), and for women between 70 and 79 years is 377. Annual screening of women between 40 and 84 years yields an NNS of 84 and an NNS/LYG of 5.3. Biennial screening of women ages 50-74 yields an NNS of 144 and an NNS/LYG of 9.1.

CONCLUSION

The NNS based on CISNET modeling results is much smaller than the NNI based on RCT data. Eighty-four women need to be screened annually between 40 and 84 years to save one life from breast cancer and 5.3 need to be screened annually to gain 1 life-year from breast cancer.

摘要

目的

我们的研究目的是估计每年需要筛查的人数(NNS)以预防一例乳腺癌死亡,以及每年每获得一个生命年需要筛查的人数(NNS/LYG),以此比较年度或两年一次的筛查乳腺 X 光检查来预防一例乳腺癌死亡。

材料和方法

美国预防服务工作组(USPSTF)委托癌症干预和监测建模网络(CISNET)对其 2009 年更新的乳腺癌筛查建议进行建模,以估计年度或两年一次的筛查乳腺 X 光检查的 NNS 和 NNS/LYG。将 NNS 值与 USPSTF 报告的 NNI 进行比较,USPSTF 使用 CISNET 结果来帮助其推荐的起始年龄和筛查间隔。

结果

对于 40-49 岁接受年度筛查乳腺 X 光检查的女性,CISNET 建模结果估计 NNS 为 746,USPSTF 根据随机对照试验(RCT)数据估算的 NNI 为 1904 的 39%。50-59 岁女性基于 CISNET 结果的 NNS 为 351(USPSTF 基于 RCT 数据估算的 NNI 为 1339 的 26%),60-69 岁女性为 233(USPSTF 基于 RCT 数据估算的 NNI 为 377 的 62%),70-79 岁女性为 377。对 40-84 岁女性进行年度筛查可获得 84 的 NNS 和 5.3 的 NNS/LYG。对 50-74 岁女性进行两年一次的筛查可获得 144 的 NNS 和 9.1 的 NNS/LYG。

结论

基于 CISNET 建模结果的 NNS 远小于基于 RCT 数据的 NNI。40-84 岁的女性每年需要筛查 84 次才能预防一例乳腺癌死亡,每年需要筛查 5.3 次才能获得 1 个生命年以预防乳腺癌。

相似文献

1
Mammography screening: a new estimate of number needed to screen to prevent one breast cancer death.乳腺 X 线筛查:降低 1 例乳腺癌死亡需要筛查的人数新估计。
AJR Am J Roentgenol. 2012 Mar;198(3):723-8. doi: 10.2214/AJR.11.7146.
2
United States Preventive Services Task Force screening mammography recommendations: science ignored.美国预防服务工作组的乳房 X 光筛查建议:被忽视的科学。
AJR Am J Roentgenol. 2011 Feb;196(2):W112-6. doi: 10.2214/AJR.10.5609.
3
Implications of CISNET modeling on number needed to screen and mortality reduction with digital mammography in women 40-49 years old.CISNET 模型对数字乳腺 X 线摄影在 40-49 岁女性中进行筛查和降低死亡率的影响。
AJR Am J Roentgenol. 2014 Dec;203(6):1379-81. doi: 10.2214/AJR.14.12646.
4
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.乳腺癌筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2009 Nov 17;151(10):716-26, W-236. doi: 10.7326/0003-4819-151-10-200911170-00008.
5
Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force.合作建模比较不同乳腺癌筛查策略:美国预防服务工作组的决策分析。
JAMA. 2024 Jun 11;331(22):1947-1960. doi: 10.1001/jama.2023.24766.
6
Outcomes of Breast Cancer Screening Strategies Based on Cancer Intervention and Surveillance Modeling Network Estimates.基于癌症干预和监测建模网络估计的乳腺癌筛查策略的结果。
Radiology. 2024 Feb;310(2):e232658. doi: 10.1148/radiol.232658.
7
Comparison of recommendations for screening mammography using CISNET models.基于 CISNET 模型的筛查性乳房 X 光检查推荐的比较。
Cancer. 2017 Oct 1;123(19):3673-3680. doi: 10.1002/cncr.30842. Epub 2017 Aug 21.
8
Clinical outcomes of modelling mammography screening strategies.乳腺钼靶筛查策略建模的临床结果
Health Rep. 2015 Dec;26(12):9-15.
9
Benefits and Harms of Breast Cancer Screening: A Systematic Review.乳腺癌筛查的获益与危害:系统评价。
JAMA. 2015 Oct 20;314(15):1615-34. doi: 10.1001/jama.2015.13183.
10
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.乳腺癌筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2016 Feb 16;164(4):279-96. doi: 10.7326/M15-2886. Epub 2016 Jan 12.

引用本文的文献

1
A Review of Machine Learning-Assisted Gas Sensor Arrays in Medical Diagnosis.机器学习辅助气体传感器阵列在医学诊断中的综述
Biosensors (Basel). 2025 Aug 20;15(8):548. doi: 10.3390/bios15080548.
2
Femoral Head Pathology in Subcapital Hip Fractures: Clinical Value and Cost-Effectiveness in a 230-Patient Case Series.股骨颈骨折中股骨头病理改变:230例患者病例系列的临床价值及成本效益分析
Diagnostics (Basel). 2025 Jan 20;15(2):234. doi: 10.3390/diagnostics15020234.
3
Clinical Validation of MyProstateScore 2.0 Testing Using First-Catch, Non-Digital Rectal Examination Urine.
使用首次排尿、非直肠指诊尿液进行MyProstateScore 2.0检测的临床验证
J Urol. 2025 May;213(5):581-589. doi: 10.1097/JU.0000000000004421. Epub 2025 Jan 21.
4
Imaging for Early Detection of Pancreatic Ductal Adenocarcinoma: Updates and Challenges in the Implementation of Screening and Surveillance Programs.用于胰腺导管腺癌早期检测的影像学检查:实施筛查和监测计划中的更新和挑战。
AJR Am J Roentgenol. 2024 Aug;223(2):e2431151. doi: 10.2214/AJR.24.31151. Epub 2024 May 29.
5
Mobile Health Solutions for Prostate Cancer Diagnostics-A Systematic Review.用于前列腺癌诊断的移动健康解决方案——一项系统综述
Clin Pract. 2023 Jul 28;13(4):863-872. doi: 10.3390/clinpract13040078.
6
Developing and validating a machine-learning algorithm to predict opioid overdose in Medicaid beneficiaries in two US states: a prognostic modelling study.开发和验证一种机器学习算法,以预测美国两个州医疗补助受益人的阿片类药物过量:预后建模研究。
Lancet Digit Health. 2022 Jun;4(6):e455-e465. doi: 10.1016/S2589-7500(22)00062-0.
7
Differences in breast cancer diagnosis by patient presentation in Ontario: a retrospective cohort study.基于患者就诊表现的安大略省乳腺癌诊断差异:一项回顾性队列研究。
CMAJ Open. 2022 Apr 5;10(2):E313-E330. doi: 10.9778/cmajo.20210254. Print 2022 Apr-Jun.
8
Implementation and Uptake of Rural Lung Cancer Screening.农村肺癌筛查的实施和采用。
J Am Coll Radiol. 2022 Mar;19(3):480-487. doi: 10.1016/j.jacr.2021.12.003. Epub 2022 Feb 7.
9
Benefits and Risks of Mammography Screening in Women Ages 40 to 49 Years.40 至 49 岁女性乳房 X 光筛查的益处和风险。
J Prim Care Community Health. 2022 Jan-Dec;13:21501327211058322. doi: 10.1177/21501327211058322.
10
Delayed or failure to follow-up abnormal breast cancer screening mammograms in primary care: a systematic review.在初级保健中延迟或未能随访异常乳腺癌筛查乳房 X 光片:系统评价。
BMC Cancer. 2021 Apr 7;21(1):373. doi: 10.1186/s12885-021-08100-3.